Cargando…
Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19
Rationale: Coronavirus disease 2019 (COVID-19) was first announced in Wuhan, and has rapidly evolved into a pandemic. However, the risk factors associated with the severity and mortality of COVID-19 are yet to be described in detail. Methods: We retrospectively reviewed the information of 1525 cases...
Autores principales: | Liu, Ze-Ming, Li, Jin-Peng, Wang, Shi-Pei, Chen, Dan-Yang, Zeng, Wen, Chen, Si-Chao, Huang, Yi-Hui, Huang, Jiang-Long, Long, Wei, Li, Man, Gao, Rong-Fen, Guo, Liang, Wu, Xiao-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532477/ https://www.ncbi.nlm.nih.gov/pubmed/33029089 http://dx.doi.org/10.7150/ijms.48396 |
Ejemplares similares
-
Procalcitonin Levels in Post TACE Infection
por: Han, Shugao, et al.
Publicado: (2020) -
Effect of procalcitonin on the prognosis of patients with COPD
por: Gong, Chen, et al.
Publicado: (2020) -
Procalcitonin levels in COVID-19 patients
por: Hu, Rui, et al.
Publicado: (2020) -
Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012) -
Investigate the relation of procalcitonin and prognosis in severe septic patients in SICU
por: Huang, S, et al.
Publicado: (2015)